Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Hochard, Arnauda; b | Oumata, Nassimaa | Bettayeb, Karimac | Gloulou, Olfad | Fant, Xavierb | Durieu, Emiliea; b | Buron, Nellye | Porceddu, Mathieue | Borgne-Sanchez, Anniee | Galons, Hervéa; d | Flajolet, Marcc | Meijer, Laurenta; *
Affiliations: [a] ManRos Therapeutics, Centre de Perharidy, Roscoff, Bretagne, France | [b] CNRS, USR3151, Station Biologique, Roscoff, Bretagne, France | [c] Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY, USA | [d] Laboratoire de Chimie Organique 2, CNRS, UMR 8601, Université Paris-Descartes, Paris, France | [e] Mitologics SAS, Hôpital Robert Debré, 48, Boulevard Sérurier, Paris, France
Correspondence: [*] Correspondence to: Laurent Meijer, ManRos Therapeutics, Centre de Perharidy, 29680 Roscoff, Bretagne, France. Tel.: +33 6 08 60 58 34; E-mail: [email protected].
Abstract: Increased production of amyloid-β (Aβ)42 peptide, derived from the amyloid-β protein precursor, and its subsequent aggregation into oligomers and plaques constitutes a hallmark of Alzheimer's disease (AD). We here report on a family of low molecular weight molecules, the Aftins (Amyloid-β Forty-Two Inducers), which, in cultured cells, dramatically affect the production of extracellular/secreted amyloid peptides. Aftins trigger β-secretase inhibitor and γ-secretase inhibitors (GSIs) sensitive, robust upregulation of Aβ42, and parallel down-regulation of Aβ38, while Aβ40 levels remain stable. In contrast, intracellular levels of these amyloids appear to remain stable. In terms of their effects on Aβ38/Aβ40/Aβ42 relative abundance, Aftins act opposite to γ-secretase modulators (GSMs). Aβ42 upregulation induced by Aftin-5 is unlikely to originate from reduced proteolytic degradation or diminished autophagy. Aftin-5 has little effects on mitochondrial functional parameters (swelling, transmembrane potential loss, cytochrome c release, oxygen consumption) but reversibly alters the ultrastructure of mitochondria. Aftins thus alter the Aβ levels in a fashion similar to that described in the brain of AD patients. Aftins therefore constitute new pharmacological tools to investigate this essential aspect of AD, in cell cultures, allowing (1) the detection of inhibitors of Aftin induced action (potential ‘anti-AD compounds’, including GSIs and GSMs) but also (2) the identification, in the human chemical exposome, of compounds that, like Aftins, might trigger sustained Aβ42 production and Aβ38 down-regulation (potential ‘pro-AD compounds’).
Keywords: Aftins, Alzheimer's disease, amyloid-β, Aβ38, Aβ40, Aβ42, γ-secretase, γ-secretase modulators, mitochondria
DOI: 10.3233/JAD-121777
Journal: Journal of Alzheimer's Disease, vol. 35, no. 1, pp. 107-120, 2013
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]